312
Participants
Start Date
July 18, 2022
Primary Completion Date
December 31, 2023
Study Completion Date
December 31, 2026
Silodosin Capsules
Silodosin is a α1A-adrenergic receptor antagonist which can relax the smooth muscle of bladder and prostate, relieves the dynamic obstruction of bladder outlet, and improves the lower urinary tract symptoms caused by BPH. The instruction of Silodosin Capsule (Qianweitai®) is 4mg/capsule,1 capsule/time, bid, after breakfast and dinner.
Ningmitai capsule
Ningmitai Capsule (Ningmitai®) is Traditional Chinese Medicine which has already used in treatment of urinary system disease (eg. CPPS, BPH) in China for more than twenty years. The instruction of Ningmitai Capsule is 0.38g/capsule, 4 capsule/time, tid.
Tamsulosin
Tamsulosin is α1A-adrenergic receptor which has used in treatment of BPH for few years. The instruction of Tamsulosin Capsule is 1 tablet at a time, 1 time a day.
NOT_YET_RECRUITING
Beijing Tiantan Hospital, Capital Medical University, Beijing
RECRUITING
Beijing Tongren Hospital, Capital Medical University, Beijing
NOT_YET_RECRUITING
The First Affiliated Hospital of Guangzhou Medical University, Guangzhou
NOT_YET_RECRUITING
Peking University Shenzhen Hospital, Shenzhen
NOT_YET_RECRUITING
The Central Hospital Of WUHAN, Wuhan
NOT_YET_RECRUITING
Wuhan No.1 Hospital, Wuhan
NOT_YET_RECRUITING
The Second Affiliated Hospital of Soochow University, Suzhou
NOT_YET_RECRUITING
Wuxi No.2 People's Hospital, Wuxi
Xintian Pharmaceutical
INDUSTRY